Ongoing work to develop, evaluate, and improve the state-level plan and response to biological public health threats.

Panelist for the New England Comparative Effectiveness Public Advisory Council (CEPAC), an independent appraisal committee to the Institute for Clinical and Economic Review (ICER).

Primary responsibility for development, implementation, and ongoing management of outpatient pharmacy utilization programs. Efforts include analyses and interventions to address internal and external performance measures, suboptimal prescribing patterns, academic detailing, and advancing electronic systems to address quality, safety and efficiency in medication use. Additional efforts include supporting institutional responses to regulatory changes and coordinating ambulatory programs with inpatient care, and other care settings, with a focus on effective transitions.